Late effects and treatment related morbidity associated with treatment of neuroblastoma patients in a tertiary paediatric centre
Author:
Affiliation:
1. ProCan®, Children’s Medical Research Institute, Faculty of Medicine and Health The University of Sydney Westmead NSW Australia
2. Cancer Centre for Children The Children's Hospital Westmead Westmead NSW Australia
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1738
Reference31 articles.
1. Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants
2. Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort
3. FriedmanDN GoodmanPJ LeisenringWM et al.Late morbidity and mortality among survivors of neuroblastoma treated with contemporary therapy: a report from the Childhood Cancer Survivor Study. Paper presented at: Journal of Clinical Oncology; May 20 2021. doi:10.1200/JCO.2021.39.15_suppl.10044
4. The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
5. High-Risk Neuroblastoma Treatment Review
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3